Clinical trials
Phase 1/2 Multiple Myeloma trials in South Korea
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
25 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 2 |
| 2013 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 4 |
| 2022 | 3 |
| 2023 | 5 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 7 |
| Terminated | 7 |
| Active, not recruiting | 6 |
| Completed | 2 |
| Unknown status | 2 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GlaxoSmithKline | 7 |
| Bayer | 2 |
| Hoffmann-La Roche | 2 |
| Regeneron Pharmaceuticals | 2 |
| Teva Branded Pharmaceutical Products R&D LLC | 2 |
| Accenture | 1 |
| Asan Medical Center | 1 |
| BeOne Medicines | 1 |
| Celgene | 1 |
| Chonnam National University Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Myeloma | 25 |
| Recurrence | 7 |
| Leukemia, Myeloid, Acute | 4 |
| Lymphoma, Non-Hodgkin | 3 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 3 |
| Hodgkin Disease | 2 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 2 |
| Lymphoma, Large B-Cell, Diffuse | 2 |
| Myelodysplastic Syndromes | 2 |
| Blast Crisis | 1 |
Trials
Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.